Learn more at LeadIQ.com

Insights

Gathering insights about Highlight Therapeutics SL…

Similar companies to Highlight Therapeutics SL

Highlight Therapeutics SL Tech Stack

Highlight Therapeutics SL uses 8 technology products and services including Google Hosted Libraries, Squarespace, Squarespace Commerce, and more. Explore Highlight Therapeutics SL's tech stack below.

Google Hosted Libraries
Content Delivery Network
Squarespace
Content Management System
Squarespace Commerce
E-commerce
Cart Functionality
E-commerce
Stimulus
Javascript Frameworks
Modernizr
Javascript Libraries
Webpack
Miscellaneous
HSTS
Security

Media & News

Highlight Therapeutics hired Carlos Paya as Executive Chairman on Apr 17th '20.
April 17, 2020: Highlight Therapeutics (“Highlight”), a clinical-stagebio pharmaceutical company developing RNA-based therapies against cancer,announces the appointment of Carlos Paya, MD, PhD,as Executive Chairman with immediate effect.The Company has also significantly expanded its Advisory Board with a number of internationally-renowned scientific and industry leaders.
Apr 17, 2020 | adventls.com

Highlight Therapeutics SL's Email Address Formats

Highlight Therapeutics SL uses at least 1 format(s):

Highlight Therapeutics SL Email Formats	Example	Percentage
FLast@highlighttherapeutics.com	JDoe@highlighttherapeutics.com	50%
FLast@highlighttherapeutics.com	JDoe@highlighttherapeutics.com	50%

Frequently Asked Questions

Where is Highlight Therapeutics SL's headquarters located?

Highlight Therapeutics SL's main headquarters is located at ES. The company has employees across 3 continents, including EuropeSouth AmericaNorth America.

What is Highlight Therapeutics SL's phone number?

You can contact Highlight Therapeutics SL's main corporate office by phone at

+34-961-10-9****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Highlight Therapeutics SL's official website and social media links?

Highlight Therapeutics SL's official website is highlighttherapeutics.com and has social profiles on LinkedIn.

How much revenue does Highlight Therapeutics SL generate?

As of September 2024, Highlight Therapeutics SL's annual revenue reached $1.8M.

What is Highlight Therapeutics SL's SIC code NAICS code?

Highlight Therapeutics SL's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Highlight Therapeutics SL have currently?

As of September 2024, Highlight Therapeutics SL has approximately 17 employees across 3 continents, including EuropeSouth AmericaNorth America. Key team members include Chief Medical Officer: Z. J. T.Vice President Finance/Global Cfo&hr: G. L. A.Head Of Data Management: P. M. L.. Explore Highlight Therapeutics SL's employee directory with LeadIQ.

What industry does Highlight Therapeutics SL belong to?

Highlight Therapeutics SL operates in the Biotechnology Research industry.

What technology does Highlight Therapeutics SL use?

Highlight Therapeutics SL's tech stack includes Google Hosted LibrariesSquarespaceSquarespace CommerceCart FunctionalityStimulusModernizrWebpackHSTS.

What is Highlight Therapeutics SL's email format?

Highlight Therapeutics SL's email format typically follows the pattern of . Find more Highlight Therapeutics SL email formats with LeadIQ.

How much funding has Highlight Therapeutics SL raised to date?

As of September 2024, Highlight Therapeutics SL has raised $27M in funding. The last funding round occurred on Feb 04, 2021 for $27M.

Highlight Therapeutics SL

Highlight Therapeutics SL

Biotechnology ResearchSpain11-50 Employees

Highlight, formerly known as Bioncotech Therapeutics S.L, is a private, clinical-stage company dedicated to unlocking the full potential of immuno-oncology.  Its lead drug candidate BO-112 is a best-in-class RNA-based therapy which has been demonstrated to initiate a powerful immune response, leveraging a unique multi-target approach to turn ‘cold’ tumors ‘hot’ and therefore visible to the immune system.  It has the potential to rescue patients who are resistant to current checkpoint inhibitor therapy.  BO-112 is currently being investigated in a range of clinical trials as a monotherapy and in combination with checkpoint inhibitors. In addition to in-house research, Highlight Therapeutics has a number of external collaborators, including Merck & Co and UCLA.

Company Overview

Headquarters: ES
Phone number: ✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+34-961-10-9****
Website: highlighttherapeutics.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 11-50

Media & News

Highlight Therapeutics hired Carlos Paya as Executive Chairman on Apr 17th '20.
Apr 17, 2020 | adventls.com

Funding & Financials

$27M
Highlight Therapeutics SL has raised a total of $27M of funding over 3 rounds. Their latest funding round was raised on Feb 04, 2021 in the amount of $27M.
$10M
Highlight Therapeutics SL's revenue is in the range of $10M

Funding & Financials

$27M
Highlight Therapeutics SL has raised a total of $27M of funding over 3 rounds. Their latest funding round was raised on Feb 04, 2021 in the amount of $27M.
$10M
Highlight Therapeutics SL's revenue is in the range of $10M

Company Leadership

Z. J. T.
Chief Medical Officer
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
G. L. A.
Vice President Finance/Global Cfo&hr
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
P. M. L.
Head Of Data Management
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. Q.
Ceo
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. O.
Quality Assurance & Pharmacovigilance Director
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

S. D. V.
Drug Supply & Qa Director
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. S.
Senior Business And Strategy Advisor
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. R. H.
Inversor
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. P.
Chairperson Of The Board
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. G.
Legal Consultant
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Highlight Therapeutics SL and Millions of Other Companies
Sign up for full access to Highlight Therapeutics SL information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.